Companies: 49,259 Total Market Cap: 131876265649315.90

KUKJEON PHARMACEUTICAL Co., Ltd

KOSDAQ-307750
Medicinal Chemicals and Botanical Products
Rank #23433
Market Cap 111.14 M
Volume 17,265
Price 2.22
Change (%) 1.48%
Country or region South Korea South Korea

KUKJEON PHARMACEUTICAL Co., Ltd's latest marketcap:

111.14 M

As of 05/22/2025, KUKJEON PHARMACEUTICAL Co., Ltd's market capitalization has reached $111.14 M. According to our data, KUKJEON PHARMACEUTICAL Co., Ltd is the 23433th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 111.14 M
Revenue (ttm) 98.39 M
Net Income (ttm) 1.25 M
Shares Out 49.97 M
EPS (ttm) 0.03
Forward PE 0.00
Ex-Dividend Date 12/27/2024
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/22/2025

KUKJEON PHARMACEUTICAL Co., Ltd's yearly market capitalization.

KUKJEON PHARMACEUTICAL Co., Ltd has seen its market value drop from ₩383.45 B to ₩154.15 B since 2020, representing a total decrease of 59.80% and an annual compound decline rate (CAGR) of 18.74%.
Date Market Cap Change (%)
05/22/2025 ₩154.15 B -9.18%
12/30/2024 ₩172.48 B -43.67%
12/28/2023 ₩306.19 B -5.74%
12/29/2022 ₩324.84 B -39.54%
12/30/2021 ₩537.31 B 40.12%
12/30/2020 ₩383.45 B

Company Profile

About KUKJEON PHARMACEUTICAL Co., Ltd

KUKJEON PHARMACEUTICAL Co., Ltd is a leading chemical total solutions provider based in South Korea. Established in 1972 and headquartered in Anyang-si, the company specializes in delivering high-quality chemical-based products and services.

Core Services & Offerings

  • Active Pharmaceutical Ingredients (API): Manufacturing and supply of APIs for pharmaceutical applications.
  • Research & Development: Comprehensive R&D services, including molecular design and technical support.
  • Quality Control & DMF Services: Ensuring product excellence through rigorous quality control and DMF compliance.

Product Portfolio

The company develops and supplies a diverse range of advanced chemical materials, including:

  • Electronic Materials: Antistatic agents, UV curing agents, and low-dielectric monomers/polymers.
  • Specialty Compounds: Low-resistance electrolytes, phosphine, silane, and boron compounds.
  • Semiconductor Materials: High-performance materials for semiconductor manufacturing.
  • Intermediates: Carbazole, boric acid, and fluorene intermediates for industrial applications.

Industry Focus

KUKJEON PHARMACEUTICAL serves a broad spectrum of industries, including:

  • Pharmaceuticals
  • Intermediate products
  • New drug synthesis
  • Specialty materials

The company holds multiple patents for its innovative manufacturing methods, reinforcing its position as a trusted partner in the chemical and pharmaceutical sectors.

Frequently Asked Questions

As of 05/22/2025, KUKJEON PHARMACEUTICAL Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $111.14 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

KUKJEON PHARMACEUTICAL Co., Ltd global market capitalization ranking is approximately 23433 as of 05/22/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 1972
IPO Date n/a
Employees 173
CEO Jongho Hong
Sector
Industry Medicinal Chemicals and Botanical Products
Address Geumgang Penterium IT Building
Anyang-si, 14056
South Korea
Website https://www.kukjeon.co.kr